Chiang-ngernthanyakun K. Sodium Glucose Cotransporter 2 Inhibitor and Glucagon-like Peptide 1 Receptor Agonist: New Glucose-lowering Medications and Cardiovascular Outcome. CM Dent J [Internet]. 2021 Apr. 29 [cited 2024 May 19];42(1):199-215. Available from: https://he01.tci-thaijo.org/index.php/cmdj/article/view/242037